¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"carrier mediated transport"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® carrier ÇÑ±Û º¸±ÕÀÚ, º¸ÃæÀÚ, º¸ÀÎÀÚ, ³ª¸£°³
¼³¸í   
  1. Áõ»ó¾øÀ̠ü³»¿¡ º´¿ø¹Ì»ý¹°ÀÌ Á¸ÀçÇÏ¿© °¨¿°ÀüÆÄÀÚÀÇ ¿ªÇÒÀ» Çϴ °³Ã¼. ÀÌ·¯ÇÑ °³Ã¼¸¦ º¸±Õ»óÅÂ(carrier state)¶ó ºÎ¸£°í ÀÖ´Ù. 2. ³ª¸£°³. ¼¼Æ÷³»ÀÇ ¹°Áú·Î¼­ ÇѰ³ ¶Ç´Â µÎ°³ÀÇ ÀüÀÚ¸¦ ¹Þ¾Æ È¯¿øµÇ³ª ±× ÈÄ ´Ù½Ã »êÈ­µÉ ¼ö Àִ °Í. 3. º¸ÀÎÀÚ. º¸Åë¿°»öü¼ºÀ̵砼º¿°»öü¼ºÀ̵砰£¿¡ ±× Á¤»óÀÇ ´ë¸³À¯ÀüÀÚ¿Í ´õºÒ¾î ¿­¼ºÀ¯ÀüÀÚ¸¦ º¸À¯Çϴ °³Ã¼. 4. ¹æ»ç¼±Çп¡¼­ ´Ù¸¥ ¹°Áú ÃßÀûÀÚ¿Í °°ÀÌ »ç¿ëµÇ¸ç, È­ÇÐÀû ¹°¸®Àû ÀÛ¿ëÀ¸·Î ±× ÃßÀûÀÚ¸¦ ¿î¹ÝÇϴ ¹°Áú. 5. ¼¼Æ÷³»¸·À» ÅëÇÑ ¿î¼ÛÀÇ °æ¿ì¿Í °°ÀÌ ¾î¶² ¹°ÁúÀÌ °¡¿ª¼ºÀ¸·Î ºÎÂøÇϴ ºÐÀÚ.
¿µ¹® cell-mediated immunity ÇÑ±Û ¼¼Æ÷¸Å°³¸é¿ª
¼³¸í   
  ¸é¿ªÀ̶õ ½Åü¸¦ ¿ÜºÎÀÇ ¹°Áú·ÎºÎÅÍ º¸È£Çϴ ÇàÀ§¸¦ ¸»ÇÑ´Ù. ¿©±â¿¡´Â Æ¯ÀÌÀû ¸é¿ª°ú ºñƯÀÌÀû ¸é¿ªÀÇ µÎ °¡Áö°¡ ÀÖ´Ù.
  
  ºñƯÀÌÀû ¸é¿ªÀ̶óÇÔÀº Æ¯Á¤ÇÑ ¹°Áú¿¡ °ü°èÇϴ ¸é¿ªÀÌ ¾Æ´Ï¶ó Æ¯Á¤ ´ë»óÀÌ ¾øÀÌ ¸ðµç ¿ÜºÎ ¹°Ã¼¿¡ ÀÛ¿ëÇÒ ¼ö Àִ ¸é¿ªÀ» ¸»ÇÑ´Ù. ¿©±â¿¡´Â ¼Òº¯ÀÇ È帧, ´«¹°ÀÇ È帧, ÇǺÎÀÇ ºñÅõ°ú¼º µîÀÇ ±â°èÀûÀΠ°Íµµ Æ÷ÇԵǰí ÇǼӿ¡ µ¹¾Æ´Ù´Ï´Â ¼¼Æ÷ Áß¿¡¼­ ºñƯÀÌÀûÀ¸·Î ¿ÜºÎÀÇ ¹°ÁúÀ» Æ÷½ÄÇϴ ¼¼Æ÷µé(¿¹¸¦ µé¸é Å«Æ÷½Ä¼¼Æ÷(macrophage)ÀǠȰµ¿µµ Æ÷ÇÔÀÌ µÈ´Ù. ¼¼Æ÷¸Å°³¸é¿ªÀ̶õ Æ¯ÀÌÇÑ ¹°ÁúÀ» °¨ÁöÇÒ ¼ö Àִ ¼¼Æ÷¸¦ »ý¼ºÇϰԠÇÏ¿© ±×°ÍÀ¸·Î ÇÏ¿©±Ý ±× ¹°ÁúÀ» Æ÷½ÄÇϰԠÇϴ °ÍÀ» ¸»ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carrier mediated transport
    ¿î¹Ýü¸Å°³¿î¹Ý
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • axonal transport
    Ãà»è¿î¹Ý
  • active transport
    ´Éµ¿¿î¹Ý
  • air medical transport
    °øÁßÀÇ·á¼ö¼Û
  • air medical transport system
    Ç×°øÀÇ·á¼ö¼Ûü°è
  • diffusion-limited transport
    È®»êÁ¦ÇÑ¿î¹Ý
  • facilitated transport
    ÃËÁø¿î¹Ý
  • iron transport
    ö¿î¹Ý
  • passive transport
    ¼öµ¿¿î¹Ý
  • antibody-dependent cell-mediated cytotoxicity
    Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
  • antibody-mediated hypersensitivity
    Ç×ü¸Å°³°ú¹Î¼º
  • antibody-mediated immunity
    Ç×ü¸Å°³¸é¿ª
  • complement mediated lysis
    º¸Ã¼¸Å°³¿ëÇØ, µµ¿òü¸Å°³¿ëÇØ
  • complement-mediated
    º¸Ã¼¸Å°³-
  • complement-mediated cytotoxicity
    º¸Ã¼¸Å°³¼¼Æ÷µ¶¼º
  • cell-mediated cytolysis
    ¼¼Æ÷¸Å°³¼¼Æ÷¿ëÇØ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carrier
    º¸±ÕÀÚ, º¸ÃæÀÚ, º¸ÀÎÀÚ, ³ª¸£°³, ¿î¹Ýü
  • heterozygous carrier
    ÀÌÁ¾Á¢ÇÕº¸ÀÎÀÚ
  • transport
    ¿î¹Ý
  • axonal transport
    Ãà»è¿î¹Ý
  • membrane transport
    ¸·¿î¹Ý
  • net transport
    ¼ø¿î¹Ý
  • transcapillary transport
    ¸ð¼¼°ü¿î¹Ý
  • transmembrane transport
    ¸·¿î¹Ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carrier mediated transport
    ¿î¹Ýü¸Å°³¿î¹Ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • active transport
    ´Éµ¿¿î¹Ý
  • axonal transport
    Ãà»è¿î¹Ý
  • catalysed transport
    Ã˸żö¼Û
  • transport component
    ¼ö¼Û¼ººÐ
  • diffusion-limited transport
    È®»êÁ¦ÇÑ¿î¹Ý
  • transport defect
    ¿î¹Ý°áÇÔ
  • facilitated transport
    ÃËÁø¿î¹Ý
  • transport host
    ¿î¹Ý¼÷ÁÖ
  • maximum transport
    ÃÖ´ë¿î¹ÝÄ¡, ÃÖ´ëÀ̵¿Ä¡
  • maximum tubular transport
    ÃÖ°í¿ä¼¼°üÀ̵¿Ä¡
  • membrane transport
    ¸·¿î¹Ý
  • transport medium
    ¿î¹Ý¹èÁö
  • net transport
    ¼ø¿î¹Ý
  • transport number
    À̵¿ºÐÀ²
  • passive transport
    ¼öµ¿¿î¹Ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Tm => transport maximum
    ÃÖ´ëÀ̵¿Ä¡
  • active transport
    ´Éµ¿(Àû)¿î¹Ý(¡­îÜê¡Úæ), ´Éµ¿(Àû)¼ö¼Û(ÒöÔÑîÜâÃáê)
  • gas transport
    °¡½º¿î¹Ý(ê¡Úæ).
  • glucose transport protein unit
    Æ÷µµ´ç ¿î¹Ý ´Ü¹é ´ÜÀ§(GLUT)
  • piece, transport
    ¿î¹Ý¼ººÐ, ¼ö¼Û¼ººÐ
  • amalgam carrier
    ¾Æ¸»°¨¼ö¼Û±â(¡­âÃáêÐï).
  • healthy carrier
    °Ç°­º¸±ÕÀÚ(ÊÙËÓË»Ëö). ±â»ý°Ç°­º¸ÃæÀÚ(ÊÙËÓ̧Ëö).
  • hemophiliac carrier
    Ç÷¿ìº´ÀÎÀÚº¸À¯ÀÚ.
  • hemophiliac carrier
    Ç÷¿ìº´ÀÎÀÚº¸À¯ÀÚ.
  • hepatitis,carrier state
    º¸±ÕÀÚ(ÜÁжíº)
  • heterozygous carrier
    ÀÌÁ¾Á¢ÇÕº¸À¯ÀÚ.
  • hod carrier s palsy
    Àâ¿ë ¿î¹ÝÀÚ ¸¶ºñ(íÚéÄê¡Úæíº Ýö).
  • hod carrier s palsy
    Àâ¿ë¿î¹ÝÀÚ¸¶ºñ(íÚéÄê¡Úæíº Ýö).
  • DNA mediated gene transfer
    DNA ¸Å°³¼ºÀ¯ÀüÀÚÀüÀÌ
  • EMMIA => enzyme modulator mediated immunoassay
    È¿¼ÒÁ¶Àý¸Å°³¸é¿ªÃøÁ¤
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carrier mediated transport
    ¿î¹Ýü¸Å°³ À̵¿
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • axonal transport= axoplasmic transport
    Ãà»è ¿î¹Ý(õîÞþê¡Úæ)
  • carrier mediated diffusion
    ´ãü(¸Å°³) È®»ê.
  • adcc(antibody dependent cell mediated cytotoxicity)
    Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øàØÚË¿á¬øàÔ¸àõ)
  • antibody dependent cell mediated cytotoxicity
    Ç×üÀÇÁ¸ ¼¼Æ÷¸Å°³ ¼¼Æ÷µ¶¼º.
  • antibody-mediated hypersensitivity
    Ç×ü¸Å°³ °ú¹Î¹ÝÀÀ
  • antibody-mediated immunity
    Ç×ü¸Å°³ ¸é¿ª
  • cell mediated hypersensitivity
    ¼¼Æ÷¸Å°³ °ú¹Î¹ÝÀÀ
  • cell mediated immunity
    ¼¼Æ÷¼º¸é¿ª.
  • cell mediated immunity deficiency syndrome
    ¼¼Æ÷(¸Å°³)¸é¿ª°áÇÌÁõÈıº.
  • cell mediated immunity deficiency syndrome
    ¼¼Æ÷¼º¸é¿ª°áÇÌÁõÈıº.
  • cell mediated lympholysis
    ¼¼Æ÷¸Å°³ ¸²ÇÁ±¸¿ëÇØ
  • cell mediated reaction
    ¼¼Æ÷¸Å°³¼º ¹ÝÀÀ
  • cell mediated reaction
    ¼¼Æ÷¸Å°³¼º ¹ÝÀÀ.
  • cell-mediated cytolysis
    ¼¼Æ÷¸Å°³ ¼¼Æ÷¿ëÇØ
  • cell-mediated cytotoxicity(CMC)
    ¼¼Æ÷¸Å°³¼º ¼¼Æ÷µ¶¼º
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transport host
    ¿î¹Ý¼÷ÁÖ
  • carrier
    º¸ÃæÀÚ
  • convalescent carrier
    ȸº¹±âº¸ÃæÀÚ
  • healthy carrier
    °Ç°­º¸ÃæÀÚ
  • permanent carrier
    ¿µ±¸º¸ÃæÀÚ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • active mediated transport
    ´Éµ¿¸Å°³¼ö¼Û (ÒöÔÑØÚË¿âÃáê)
  • mediated transport
    ¸Å°³¼ö¼Û(ØÚË¿âÃáê)
  • passive mediated transport
    ¼öµ¿ ¸Å°³¿î¹Ý(áôÔÑØÚË¿ê¡Úæ)
  • antibody mediated hypersensitivity
    Ç×ü ¸Å°³ °ú¹ÎÁõ(ù÷ô÷ØÚ˿ΦÚÂñø)
  • cell-mediated immunity
    ¼¼Æ÷¸Å°³¸é¿ª(á¬øàØÚË¿Øóæ¹)
  • F-mediated transduction
    F¸Å°³(ØÚË¿) ÇüÁúµµÀÔ(û¡òõÓôìý)
  • intron-mediated recombination
    ÀÎÆ®·ÐÁß°³(ñéË¿) ÀçÁ¶ÇÕ(î¢ðÚùê)
  • prophage-mediated conversion
    ÇÁ·ÎÆäÀÌÁö ¸Å°³ Àüȯ(ØÚË¿ï®üµ)
  • receptor-mediated endocytosis
    ¼ö¿ëü¸Å°³ ¼¼Æ÷³» ÀÌÀÔ(áôé»ô÷ØÚË¿á¬øàÒ®ì¹ìý)
  • acyl-carrier protein
    ¾Æ½Ç¿î¹Ý ´Ü¹éÁú (ê¡ÚæÓ±ÛÜòõ)
  • ATP-ADP carrier
    ATP-ADP ¿î¹Ýü(ê¡Úõô÷)
  • biotin carboxyl carrier protein
    ¹ÙÀÌ¿Àƾ Ä«¸£º¹½Ç ¿î¹Ý´Ü¹éÁú(ê¡ÚæÓ±ÛÜòõ)
  • carboxyl carrier protein
    Ä«¸£º¹½Ç ¿î¹Ý´Ü¹éÁú(ê¡ÚæÓ±ÛÜòõ)
  • carrier
    "ij¸®¾î, ¿î¹Ýü(ê¡Úæô÷)"
  • carrier ampholyte
    ij¸®¾î ¾ç¼ºÀüÇØÁú(Õ×àõï³ú°òõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transport
    ¼ö¼Û, ¿î¹Ý
  • carrier
    ¹Ý¼ÛÆÄ, ij¸®¾î, º¸À¯ÀÚ, º¸±ÕÀÚ, ´ãü
  • healthy carrier
    °Ç°­º¸±ÕÀÚ, °Ç°­º¸ÃæÀÚ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CML carboxymethyl lysine; cell-mediated lymphocytotoxicity; cell-mediated lympholysis; central motor lat...
TM technology management; tectorial membrane; temperature by mouth; temporalis muscle; temporomandibula...
ACP accessory conduction pathway; acid phosphatase; acyl carrier protein; American College of Pathologis...
BCCP biotin carboxyl carrier protein
CF calcaneal fibular [ligament]; calcium leucovorin; calf blood flow; calibration factor; cancer-free; ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CTE Constitutive Transport Element
ETC Electron transport chain
FATP Fatty acid transport protein
HAChT High affinity choline transport
IFT Intraflagellar transport
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • carrier mediated transport
    ¿î¹Ýü ¸Å°³ À̵¿
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • active transport
    ´Éµ¿ À̵¿
    È®»ê¿¡ ÀÇÇØ¼­°¡ ¾Æ´Ï¶ó ¿î¹Ýü¿¡ ÀÇÇØ ¿¡³ÊÁö¸¦ ¼ÒºñÇØ °¡¸ç ³óµµ¿¡ ¿ªÇàÇØ¼­ ¹°ÁúÀÌ À̵¿µÇ´Â Çö»ó.
  • axonal transport
    Ãà»è ¿î¹Ý
  • carbon dioxide transport
    ÀÌ»êȭź¼Ò ¿î¹Ý
  • co-transport
    °øµ¿ ¿î¹Ý, °øµ¿ À̵¿, °øµ¿ ¼ö¼Û)
  • downhill transport
    Çǵ¿ ¿î¹Ý
  • oxygen transport mechanism
    »ê¼Ò ¿î¹Ý ±âÀü
  • passive transport
    Çǵ¿Àû ¿î¹Ý, Çǵ¿Àû À̵¿, ¼öµ¿Àû À̵¿
  • sodium transport system
    ³ªÆ®·ý ¿î¹Ý°è
  • transport
    ¼ö¼Û, ¿î¼Û
    »ý¹°°è¿¡ ÀÖ´Â ¹°ÁúÀÇ À̵¿À¸·Î¼­, ƯÈ÷ ¼¼Æ÷ÀÇ ³»¿Ü³ª »óÇÇÃþÀ» ÅëÇØ¼­ À̵¿ÇÏ´Â °Í.
  • transport oxygen
    »ê¼Ò ¿î¹Ý
  • virus transport medium
    ¹ÙÀÌ·¯½º ¿î¼Û ¹èÁö
  • aldosterone-mediated sodium
    ¾Ëµµ½ºÅ×·Ð Áß°³µÈ ³ªÆ®·ý
  • amalgam carrier
    ¾Æ¸»°¨ ¼ö¼Û±â
    ¹°··¹°··ÇÑ ¾Æ¸»°¨À» »èÁ¦ÇÑ ¿Íµ¿À̳ª Ʋ ¼ÓÀ¸·Î ¿î¹ÝÇϴµ¥ »ç¿ëÇÏ´Â µµ±¸.
  • antibody dependent cell mediated cytotoxicity
    Ç×ü ÀÇÁ¸ ¼¼Æ÷ ¸Å°³ ¼¼Æ÷ µ¶¼º, Ç×ü ÀÇÁ¸¼º ¼¼Æ÷ ¸Å°³¼º ¼¼Æ÷ µ¶¼º
  • bacteria carrier
    ¼¼±Õ º¸±ÕÀÚ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
receptor mediated endocytosis Endocytosis of molecules by means of a specific receptor protein that normally resides in a coated pit, but may enter this structure after complex formation occurs. The structure then forms a coated vesicle that delivers its contents to the endosome whence it may enter the cytoplasm or the lysosomal compartment. Many bacterial toxins and viruses enter cells by this route.
(18 Nov 1997)
cell-mediated immunity <immunology> Immune response that involves effector T lymphocytes and not the production of humoral antibody.
Responsible for allograft rejection, delayed hypersensitivity and in defence against viral infection and intracellular protozoan parasites.
(26 Mar 1998)
cell-mediated reaction Immunological reaction of the delayed type, involving chiefly T lymphocytes, important in host defense against infection, in autoimmune diseases, and in transplant rejection.
See: skin test.
(05 Mar 2000)
acetoacetyl-acyl carrier protein synthase <enzyme> E coli enzyme, that catalyses condensation of malonyl-acyl carrier protein plus acetyl-acyl carrier protein; not inhibited by cerulenin
Registry number: EC 2.3.1.-
Synonym: acetoacetyl-acp synthase
(26 Jun 1999)
acyl-(acyl-carrier-protein)-phospholipid acyltransferase <enzyme> Catalyses the formation of phosphatidylethanolamine from acyl-acyl carrier protein and 2-acyl-sn-glycero-3-phosphoethanolamine
Registry number: EC 2.3.1.40
Synonym: 2-acyl-gpe acyltransferase, 2-acylglycerophosphoethanolamine acyltransferase
(26 Jun 1999)
acyl-(acyl-carrier-protein)-UDP-N-acetylglucosamine acyltransferase <enzyme> E coli enzyme involved in lipid a biosynthesis; uses beta-hydroxymyristoyl-acyl carrier protein to form udp-3-monoacyl-n-acetylglucosamine; amino acid sequence given in second source
Registry number: EC 2.3.1.129
Synonym: udp-aguatransferase, lpxa protein, udp-n-acetylglucosamine-3-acyltransferase, udp-n-acetylglucosamine 3-o-acyltransferase, udp-3-o-(r-3-hydroxymyristoyl)glucosamine-n-acyltransferase, lpxd protein, fira gene product, fira protein
(26 Jun 1999)
acyl carrier protein <protein> A small (77 peptides long) protein which binds six other enzymes involved in fatty acid synthesis. It was first isolated in E. Coli bacteria.
(09 Oct 1997)
acyl carrier protein acylase <enzyme> From E coli
Registry number: EC 2.3.1.-
Synonym: acp acylase
(26 Jun 1999)
amalgam carrier An instrument used to transport triturated amalgam to a cavity preparation and to deposit it therein.
(05 Mar 2000)
beta-hydroxyacyl-(acyl-carrier-protein)dehydrase <enzyme> In fatty acid synthesis; specific for acyl carrier protein; cannot use acyl CoA; see also faba gene product
Registry number: EC 4.2.1.-
Synonym: beta-ohacyl-acp dehydrase, beta-hydroxyacyl-acyl carrier protein dehydratase, fabz gene product
(26 Jun 1999)
galactose-diphosphoglycosyl carrier lipid synthetase <enzyme> Catalyses synthesis of gcl-pp-gal from udp gal and p-gcl; also catalyses exchange between the uridylyl moiety of udpgal and ump
Registry number: EC 2.4.1.-
(26 Jun 1999)
malonyl-CoA-acetyl CoA-acyl carrier protein S-acyltransferase <enzyme> Specific for either malonyl-CoA or acetyl-CoA; a component of fatty acid synthase
Registry number: EC 2.8.3.-
Synonym: mcoa-acoa acp acyltransferase
(26 Jun 1999)
manifesting carrier An organism heterozygous for what is ordinarily a recessive condition which, as a result of special mechanisms (such as lyonization, allelic exclusion, or a deletion in the homologous chromosome), has phenotypic manifestations.
Synonym: manifesting carrier.
(05 Mar 2000)
genetic carrier An unaffected heterozygote bearing a usually harmful recessive gene, a cancer that bears a dominant but latent age-dependent trait to have offspring with unbalanced karyotypes.
(05 Mar 2000)
carrier 1. <genetics, microbiology> An individual who does not display the symptoms of a disease, but harbors the pathogen which causes it, or has the gene (or genes) for it, and can transmit the disease to others either through interacting with other individuals, or by passing the disease-causing gene (or genes) to offspring.
2. <pharmacology> A substance which transports things, such as a carrier protein.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cell-mediated immunity
    ¼¼Æ÷(¸Å°³)¼º ¸é¿ª(¼¼Æ÷¸·¿¡ ºÎÂøÇÏ´Â Ç×üÀÇ Á߻꿡 ÀÇÇÑ
  • transport
    ¼ö¼ÛÇÏ´Ù
  • International Air Transport association
    ±¹Á¦ Ç×°ø¿î¼ÛÇùȸ(IATA)
  • air transport
    °øÁß¼ö¼Û;°ø¼ö
  • hypersonic transport
    ±ØÃÊÀ½¼Ó
  • hypersonic transport
    ±ØÃÊÀ½¼Ó¼ö¼Û±â
  • mass transport
    (¹ö½º,ÀüÂ÷ µîÀÇ °ø°ø ¼ö¼Û ±â°ü¿¡ ÀÇÇÑ) ´ë·® ¼ö¼Û;´ë·® ¼ö¼Û ±â°ü
  • mechanical transport
    ÀÚµ¿Â÷ ºÎ´ë
  • transport
    ¼ö¼Û(±â,¼±,±â°ü);ȲȦ;µµÃë;¿­Áß;À¯Çü¼ö )
  • transport
    ¼ö¼ÛÇÏ´Ù;µµÃë(¿­Áß)ÄÉ ÇÏ´Ù;À¯Çü¿¡ óÇÏ´Ù;Á×ÀÌ´Ù
  • transport House
    ³ëµ¿´ç º»ºÎ
  • transport ship
    ¿î¼Û¼±
  • carrier
    º¸±ÕÀÚ
  • air carrier
    Ç×°øÈ¸»ç;Ç×°ø±â
  • atomic carrier
    ¿øÀÚ·Â Ç×°ø ¸ðÇÔ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á